Private Sector Investment in Research and Development in Canada

December 15, 2025

Submission to the House of Commons Standing Committee on Science and Research

In response to the Standing Committee’s study on how to best promote and grow private sector investment in research and development in Canada, UAEM’s Canadian Access Team submitted a brief that urges the Canadian government to strengthen the government’s commitment to funding biomedical R&D that addresses public health needs, and ensures access is a priority of the commercialization of innovation.

In the brief, UAEM outlined three key priorities:

1. Strengthen public funding of biomedical R&D, especially to fund neglected health areas and public health priorities.

2. Tie federal funding of biomedical R&D to access conditions.

3. Create federal guidelines for universities on adopting policies to support access to innovation and allocate resources to support those efforts.

Previous
Previous

Letter to Gilead on Access to Lenacapavir in Latin America and the Caribbean

Next
Next

Pledge to Protect Science and Advance Equitable Access to Medicines